Urogen Pharma Ltd (URGN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre Partager sur 𝕏

Cours de l'action

Code mnémonique : URGN Marché : NMS

Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités

• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette

90 derniers jours

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Données d'entreprise

Inscrivez-vous pour avoir accès à la description de l'entreprise et aux données fondamentales (capitalisation boursière, actions en circulation, rendement du dividende, % d'actions détenues par des initiés, etc.)

Rechercher

Télécharger les transactions

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre

Date de notification	Date de transaction	A/V Type de transaction	Initié et/ou titre	Nb. d'actions Prix Valeur	Nombre d'actions	Prix	Valeur totale
2024-03-20	2024-03-18	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	12 000 -7.9% 14,05 168 600 USD	12 000 -7.9%	14,05	168 600 USD
2024-02-02	2024-01-31	V Vente	Smith Jason Drew General Counsel Dirigeant	3 328 -12.4% 15,74 52 383 USD	3 328 -12.4%	15,74	52 383 USD
2024-02-02	2024-01-31	V Vente	Smith Jason Drew General Counsel Dirigeant	1 248 -5.9% 15,74 19 644 USD	1 248 -5.9%	15,74	19 644 USD
2024-02-02	2024-01-31	V Vente	Smith Jason Drew General Counsel Dirigeant	417 -2.2% 15,74 6 564 USD	417 -2.2%	15,74	6 564 USD
2024-02-02	2024-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	1 894 -1.2% 15,74 29 812 USD	1 894 -1.2%	15,74	29 812 USD
2024-02-02	2024-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	758 -0.5% 15,74 11 931 USD	758 -0.5%	15,74	11 931 USD
2024-02-02	2024-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	1 137 -0.8% 15,74 17 896 USD	1 137 -0.8%	15,74	17 896 USD
2023-09-05	2023-08-31	V Vente	Smith Jason Drew General Counsel Dirigeant	3 800 -17.1% 18,01 68 438 USD	3 800 -17.1%	18,01	68 438 USD
2023-02-02	2023-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	661 -0.4% 10,12 6 689 USD	661 -0.4%	10,12	6 689 USD
2023-02-02	2023-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	991 -0.7% 10,12 10 029 USD	991 -0.7%	10,12	10 029 USD
2023-02-02	2023-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	248 -0.2% 10,12 2 510 USD	248 -0.2%	10,12	2 510 USD
2023-02-02	2023-01-31	V Vente	Smith Jason Drew General Counsel Dirigeant	1 227 -8.1% 10,12 12 417 USD	1 227 -8.1%	10,12	12 417 USD
2023-02-02	2023-01-31	V Vente	Smith Jason Drew General Counsel Dirigeant	409 -3.1% 10,12 4 139 USD	409 -3.1%	10,12	4 139 USD
2022-11-02	2022-10-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	258 -1.1% 11,85 3 057 USD	258 -1.1%	11,85	3 057 USD
2022-09-02	2022-08-31	V Vente	Smith Jason Drew General Counsel Dirigeant	3 606 -22.8% 7,21 25 999 USD	3 606 -22.8%	7,21	25 999 USD
2022-08-25	2022-08-01	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	259 -1.1% 7,81 2 023 USD	259 -1.1%	7,81	2 023 USD
2022-05-03	2022-04-30	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	254 -1.1% 6,62 1 681 USD	254 -1.1%	6,62	1 681 USD
2022-02-02	2022-01-31	V Vente	Smith Jason Drew General Counsel Dirigeant	414 -5.3% 7,58 3 138 USD	414 -5.3%	7,58	3 138 USD
2022-02-02	2022-01-31	V Vente	Barrett Elizabeth A. Chief Executive Officer Dirigeant	5 960 -1.9% 7,58 45 177 USD	5 960 -1.9%	7,58	45 177 USD
2022-02-02	2022-01-31	V Vente	Barrett Elizabeth A. Chief Executive Officer Dirigeant	2 235 -0.7% 7,58 16 941 USD	2 235 -0.7%	7,58	16 941 USD
2022-02-02	2022-01-31	V Vente	Henderson Molly Chief Financial Officer Dirigeant	331 -5.9% 7,58 2 509 USD	331 -5.9%	7,58	2 509 USD
2022-02-02	2022-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	1 099 -4.5% 7,58 8 330 USD	1 099 -4.5%	7,58	8 330 USD
2022-02-02	2022-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	275 -1.2% 7,58 2 085 USD	275 -1.2%	7,58	2 085 USD
2022-01-28	2022-01-26	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	111 -0.5% 8,09 898 USD	111 -0.5%	8,09	898 USD
2022-01-07	2022-01-04	V Vente	Barrett Elizabeth A. Chief Executive Officer Dirigeant	46 968 -13.6% 9,15 429 757 USD	46 968 -13.6%	9,15	429 757 USD
2021-12-02	2021-11-30	V Vente	Smith Jason Drew General Counsel Dirigeant	3 803 -35.1% 12,03 45 750 USD	3 803 -35.1%	12,03	45 750 USD
2021-12-02	2021-11-30	V Vente	Henderson Molly Chief Financial Officer Dirigeant	2 587 -34.5% 12,03 31 122 USD	2 587 -34.5%	12,03	31 122 USD
2021-11-19	2021-11-18	A Achat	Schoenberg Mark Chief Medical Officer Dirigeant	160 +0.7% 13,10 2 096 USD	160 +0.7%	13,10	2 096 USD
2021-11-02	2021-11-01	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	258 -1.2% 17,16 4 427 USD	258 -1.2%	17,16	4 427 USD
2021-10-28	2021-10-27	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	107 -0.5% 16,32 1 746 USD	107 -0.5%	16,32	1 746 USD
2021-05-18	2021-05-17	A Achat	Smith Jason Drew General Counsel Dirigeant	2 500 +inf% 15,71 39 275 USD	2 500 +inf%	15,71	39 275 USD
2021-05-04	2021-04-30	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	243 -1.1% 20,00 4 860 USD	243 -1.1%	20,00	4 860 USD
2021-02-02	2021-01-31	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	1 076 -4.9% 22,07 23 747 USD	1 076 -4.9%	22,07	23 747 USD
2021-01-26	2021-01-26	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	100 -0.5% 22,12 2 212 USD	100 -0.5%	22,12	2 212 USD
2020-12-15	2020-12-14	A Achat	Barrett Elizabeth A. Chief Executive Officer Dirigeant	10 000 +4.6% 18,50 185 000 USD	10 000 +4.6%	18,50	185 000 USD
2020-12-07	2020-12-04	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	662 -3.2% 19,85 13 141 USD	662 -3.2%	19,85	13 141 USD
2020-10-28	2020-10-26	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	101 -0.5% 20,95 2 116 USD	101 -0.5%	20,95	2 116 USD
2020-10-16	2020-10-15	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	1 017 -8.9% 21,72 22 089 USD	1 017 -8.9%	21,72	22 089 USD
2020-10-16	2020-10-15	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	407 -3.4% 21,82 8 882 USD	407 -3.4%	21,82	8 882 USD
2020-10-16	2020-10-15	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	976 -7.6% 21,80 21 276 USD	976 -7.6%	21,80	21 276 USD
2020-09-08	2020-09-04	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	348 -1.8% 20,20 7 030 USD	348 -1.8%	20,20	7 030 USD
2020-09-01	2020-09-01	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	509 -6.1% 22,82 11 615 USD	509 -6.1%	22,82	11 615 USD
2020-07-28	2020-07-27	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	70 -0.4% 23,51 1 646 USD	70 -0.4%	23,51	1 646 USD
2020-07-28	2020-07-27	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	141 -1.9% 23,51 3 315 USD	141 -1.9%	23,51	3 315 USD
2020-06-05	2020-06-04	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	349 -1.9% 27,51 9 602 USD	349 -1.9%	27,51	9 602 USD
2020-05-20	2020-05-20	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	358 -4.8% 25,07 8 975 USD	358 -4.8%	25,07	8 975 USD
2020-04-28	2020-04-27	V Vente	Mullennix Stephen Chief Operating Officer Dirigeant	145 -1.4% 24,35 3 531 USD	145 -1.4%	24,35	3 531 USD
2020-04-28	2020-04-27	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	70 -0.4% 24,35 1 705 USD	70 -0.4%	24,35	1 705 USD
2020-04-28	2020-04-27	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	141 -2.2% 24,35 3 433 USD	141 -2.2%	24,35	3 433 USD
2020-02-24	2020-02-20	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	360 -5.6% 29,68 10 685 USD	360 -5.6%	29,68	10 685 USD
2020-02-18	2020-02-14	V Vente	Mullennix Stephen Chief Operating Officer Dirigeant	612 -5.9% 28,04 17 160 USD	612 -5.9%	28,04	17 160 USD
2020-01-28	2020-01-27	V Vente	Mullennix Stephen Chief Operating Officer	684 -7.3% 29,26 20 014 USD	684 -7.3%	29,26	20 014 USD
2020-01-28	2020-01-27	V Vente	Schoenberg Mark Chief Medical Officer	322 -3.4% 29,15 9 386 USD	322 -3.4%	29,15	9 386 USD
2020-01-28	2020-01-27	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer	667 -13.1% 29,28 19 530 USD	667 -13.1%	29,28	19 530 USD
2019-11-22	2019-11-21	A Achat	Barrett Elizabeth A. Chief Executive Officer Dirigeant	7 530 +83.5% 28,00 210 840 USD	7 530 +83.5%	28,00	210 840 USD
2019-11-22	2019-11-20	A Achat	Barrett Elizabeth A. Chief Executive Officer Dirigeant	7 470 +482.6% 28,00 209 160 USD	7 470 +482.6%	28,00	209 160 USD
2019-11-22	2019-11-20	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	354 -9.3% 28,41 10 057 USD	354 -9.3%	28,41	10 057 USD
2019-11-21	2019-11-19	A Achat	Schoenberg Mark Chief Medical Officer Dirigeant	1 960 +32.6% 28,17 55 213 USD	1 960 +32.6%	28,17	55 213 USD
2019-11-18	2019-11-15	A Achat	Barrett Elizabeth A. Chief Executive Officer Dirigeant	1 548 +inf% 26,00 40 248 USD	1 548 +inf%	26,00	40 248 USD
2019-11-18	2019-11-14	V Vente	Mullennix Stephen Chief Operating Officer Dirigeant	608 -7.3% 26,00 15 806 USD	608 -7.3%	26,00	15 806 USD
2019-09-06	2019-09-04	V Vente	Schoenberg Mark Chief Medical Officer	343 -5.4% 33,92 11 635 USD	343 -5.4%	33,92	11 635 USD
2019-08-22	2019-08-20	V Vente	PFREUNDSCHUH PETER P. Chief Financial Officer Dirigeant	1 416 -34.0% 33,07 46 827 USD	1 416 -34.0%	33,07	46 827 USD
2019-08-16	2019-08-15	V Vente	Mullennix Stephen Chief Operating Officer Dirigeant	608 -8.5% 31,65 19 243 USD	608 -8.5%	31,65	19 243 USD
2019-05-16	2019-05-14	V Vente	Mullennix Stephen Chief Operating Officer	608 -10.2% 37,98 23 092 USD	608 -10.2%	37,98	23 092 USD
2019-03-22	2019-03-21	A Achat	Schoenberg Mark Chief Medical Officer	272 +6.3% 37,01 10 066 USD	272 +6.3%	37,01	10 066 USD
2019-03-07	2019-03-06	V Vente	Schoenberg Mark Chief Medical Officer Dirigeant	1 991 -31.5% 37,30 74 264 USD	1 991 -31.5%	37,30	74 264 USD
2019-03-07	2019-02-14	V Vente	Mullennix Stephen Chief Operating Officer Dirigeant	2 804 -39.9% 37,30 104 589 USD	2 804 -39.9%	37,30	104 589 USD
2017-11-29	2017-11-28	V Vente	ProQuest Investments IV, L.P. Large shareholder	177 807 -12.5% 40,51 7 202 962 USD	177 807 -12.5%	40,51	7 202 962 USD
2017-11-29	2017-11-27	V Vente	ProQuest Investments IV, L.P. Large shareholder	31 491 -2.2% 41,12 1 294 910 USD	31 491 -2.2%	41,12	1 294 910 USD